E-viri
-
WHO drug information, 07/2017, Letnik: 31, Številka: 3Journal Article
Ireland - The HPRA has informed health professionals that amoxicillin is associated with a very rare risk of drug reaction with eosinophilia and systemic symptoms (DRESS). The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) had reviewed a signal and had recommended that DRESS should be added to the very rare severe cutaneous adverse reactions mentioned in the product information for amoxicillin-containing medicines. * HPRA Drug Safety Newsletter, 82nd Edition.
